Literature DB >> 910698

Effect of magnesium chloride on electrical stability of the heart.

M F Ghani, M Rabah.   

Abstract

The effect of magnesium chloride on the ventricular fibrillation threshold (VFT) and the threshold for the ventricular premature contraction (VPCT) was studied in 20 dogs. Seven of the dogs were pre-treated with digitalis and four were in the form of heart-lung preparations. In the anesthetized, intact dogs, the VPCT was 0.19 +/- 0.01 mV. After treatment with magnesium chloride (100 mg. per kilogram intravenously), the VPCT increased by 53% (P less than 0.01). In the same group of animals, the VFT averaged 0.50 +/- 0.06 mV., which more than doubled after administration of magnesium. The threshold of VPC in the digitalis-treated dogs measured 0.18 +/- 0.01 mV; this value doubled after magnesium. The VFT in the digitalized dogs also increased after magnesium; however, resistance to electrical defibrillation was encountered in this group. In the heart-lung preparations, VPCT improved by 72% and a gain of 131% in the VFT followed magnesium administration. The results suggest that magnesium increases the ventricular threshold of arrhythmias in normal, denervated (heart-lung preparations) and also digitalis-treated hearts and, thus, indicate its usefulness in the treatment of ventricular arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 910698     DOI: 10.1016/s0002-8703(77)80129-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Increase in magnesium plasma level after orally administered trimagnesium dicitrate.

Authors:  C Wilimzig; R Latz; W Vierling; E Mutschler; T Trnovec; S Nyulassy
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 2.  Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence.

Authors:  Koon K Teo; Salim Yusuf
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

3.  Ventricular arrhythmias in patients with myocardial infarction and ischaemia. Relationship to serum potassium and magnesium.

Authors:  R J Solomon
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

4.  Ischaemic heart disease. An epidemiological perspective with special reference to electrolytes.

Authors:  H Karppanen
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

5.  The influence of elevated Mg2+ concentrations on cardiac electrophysiologic parameters.

Authors:  G Stark; U Stark; E Pilger; K Hönigl; H Bertuch; H A Tritthart
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

Review 6.  Magnesium, myocardial ischaemia and arrhythmias. The role of magnesium in myocardial infarction.

Authors:  A Dubey; R Solomon
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

7.  Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials.

Authors:  K K Teo; S Yusuf; R Collins; P H Held; R Peto
Journal:  BMJ       Date:  1991-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.